Athersys Inc 4LS-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 3:32 PM CET
1.53quote price arrow down-0.15 (-8.93%)
Volume
700
52 week range
1.03 - 4.14

...

Loading . . .

KEY STATS

  • Open1.47
  • Day High1.57
  • Day Low1.47
  • Prev Close1.57
  • 52 Week High4.14
  • 52 Week High Date04/02/20
  • 52 Week Low1.03
  • 52 Week Low Date03/13/20
  • Market Cap403.07M
  • Shares Out197.59M
  • 10 Day Average Volume2,217.55
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change36.61

RATIOS/PROFITABILITY

  • EPS (TTM)-0.32
  • P/E (TTM)-4.78
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Athersys Inc News

There is no recent news for this security.

Latest 4LS-FF News From Our Partners

QUOTE FINDER

Profile

MORE
Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of...
Ismail Kola
Chairman
William Lehmann J.D., Ph.D.
President
Ivor Macleod
Chief Financial Officer
John Harrington Ph.D.
Executive Vice President
Address
3201 Carnegie Ave
Cleveland, OH
44115-2634
United States